Danish pharmaceutical company Novo Nordisk's results are affecting the entire nation's economy. The quarterly report will be released tomorrow - and profits are expected to fall by billions. Novo Nordisk has lost some momentum, says Per Hansen, savings economist at Nordnet in Denmark.
BusinessAfter a turbulent year, new challenges await pharmaceutical giant Novo Nordisk. Competitors are poised to capitalize as the patent on its best-selling drug expires in several markets.
BusinessThe Danish pharmaceutical giant Novo Nordisk, known for the weight loss preparations Ozempic and Wegovy, reports a full-year sales figure that beats market expectations. It's a really good ending to a turbulent year, says Per Hansen, investment economist at Nordnet in Denmark.
Business
